SUMMARY
these symptoms have appeared. Also, there is clear consensus that aortic valve surgery is indicated when angina and syncope emerge. In considering the pathophysiology of heart failure in AS, pressure overload to the LV progresses to diastolic dysfunction, in addition to systolic dysfunction or before systolic function deteriorates. Dineen, et al demonstrated that LV ejection fraction was preserved in 60% of patients with AS and heart failure; ie, they developed diastolic heart failure.
3) Lund, et al also found that systolic and diastolic LV dysfunction were preoperative risk factors for early and late mortality after aortic valve replacement. 4 ) However, we have found that the preoperative course of AS patients with diastolic heart failure is superior to those with systolic heart failure. Therefore, we classified heart failure in AS into systolic and diastolic failure using echocardiography and cardiac catheterization, and retrospectively compared disease progression in AS between these 2 types of heart failure.
METHODS
We retrospectively studied 52 patients (22 males, 30 females) who had undergone aortic valve replacement (AVR) following a diagnosis of isolated AS at our institution during a 12 year period from January 1993 to January 2005. Among these 52 patients, 5 developed angina, 3 syncope, and 34 other cardiac symptoms, including low output and dyspnea. However, 10 patients were asymptomatic despite critical stenosis less than 0.8 cm 2 in the aortic valve area. The etiology of this disease involved rheumatic fever in 2 patients and bicuspid valves in 7. However, in most patients, the AS developed as a result of the atherosclerotic process. Echocardiography Transthoracic M-mode and Doppler echocardiography were performed in all patients. LV diastolic and systolic dimensions (Dd and Ds, respectively) were determined by the standard M-mode criteria and LV fractional shortening (FS) and ejection fraction (EF) were calculated from the following formulae; (Dd-Ds)/Dd and (Dd 3 -Ds 3 )/Dd 3 , respectively. Aortic valve area (AVA) was measured noninvasively using a Doppler continuity equation.
The parameters of LV diastolic function were also measured using transmitral flow: the early diastolic flow velocity (E), atrial filling velocity (A), and the deceleration time of the early diastolic flow (DCT). Cardiac catheterization analysis: In all patients, cardiac catheterization was performed to measure right and left heart pressures, and coronary and LV angiographies were obtained when the patients had been stabilized by medical treatment. Coronary artery disease (CAD) was defined as narrowing of the lumen diameter of more than 75% according to the guidelines of the American Heart Association. AVA was also calculated using the Gorlin formula based on the differences Using the echocardiography and catheterization data obtained before AVR we classified 52 patients with AS into 2 groups according to LVEF; 1) normal LVEF (EF ≥ 45%) and 2) low LVEF (EF < 45%, group 3; n = 9). Patients with normal LVEF were divided into 2 further groups according to the PWP; PWP < 16 mmHg: group 1; n = 35 and PWP ≥ 16 mmHg: group 2; n = 8. Clinical endpoint: The clinical endpoint was defined as cardiovascular death (death from heart failure and postoperative death related to cardiovascular problems) that occurred within 30 days after AVR. During these 12 years, 4 patients who died as a result of noncardiac problems, such as infection, were excluded at the time of entry. We also evaluated an additional clinical endpoint, defined as cardiovascular death during the further postoperative course up to 30 days. Statistical analysis: Statistical analysis was performed using the unpaired t-test, chi-square test, and ANOVA. Cox proportional hazards model analysis (both univariate and multivariate) was performed to determine which clinical, echocardiographic, and hemodynamic parameters were significantly related to clinical outcomes.
All data are expressed as the mean ± standard deviation, and P values < 0.05 were considered significant.
RESULTS
Age, gender, and clinical profiles were not different at baseline among groups 1, 2, and 3. However, the incidences of hypertension, hyperlipidemia, diabetes mellitus, smoking history, and history of rheumatic fever were slightly lower in group 2 (Table I ).
In the echocardiographic data, there were no differences in LV diastolic dimension between the 3 groups. However, the increment of LV systolic dimension resulted in a lower EF in group 3. Doppler transmitral flow data and AVA calculated from Doppler pressure gradients showed no differences among these 3 groups. Coronary angiography revealed CAD in 5 patients in group 1 and in 1 patient in group 2, but none in group 3. Cardiac index and AVA from catheterization and the incidence of concomitant CAD were not significantly different between these 3 groups.
Cardiovascular death after AVR occurred in 3 patients (33%) in group 3 irrespective of PWP (1 in PWP < 16 mmHg, 2 in PWP ≥ 16 mmHg), but not in groups 1 and 2 (P < 0.0032) (Table II) . These 3 patients died as a result of multiple organ failure due to low output heart failure during the early postoperative _ NAKAGAWA, ET AL course. Furthermore, no further cardiovascular deaths or admissions for heart failure occurred in the long-term prognosis after 30 days in the postoperative course (Table II) . In logistic regression analysis for predicting the prognosis after AVR using poor EF (less than 45%), elevated PWP (more than 16 mmHg), advanced age (over 70 years old), and the presence of CAD, multivariate analysis revealed that only EF was a significant independent predictor (Table III) .
DISCUSSION
In patients with AS, symptoms related to heart failure usually appear with the deterioration of LV systolic function. However, the present study found that some patients with AS also became symptomatic through the progression of LV diastolic dysfunction and exhibited elevated pulmonary wedge pressure despite the preservation of LV systolic function. In these patients, it was suggested that LV diastolic heart failure was a consequence of chronic pressure overload prior to deterioration of LV systolic function. Furthermore, some patients with systolic heart failure exhibited a poor outcome after AVR, but the occurrence of diastolic heart failure did not affect the outcome. Thus, the development of diastolic heart In observing the prognosis of patients with AS, Ross and Braunwald elucidated that their life expectancy worsened once symptoms, inclusive of angina, syncope and heart failure, appeared.
1) Currently, although it has been observed that the risk of sudden death is not high while AS patients remain asymptomatic, 2) some investigators have recommended early valve surgery before the development of cardiac symptoms to prevent left ventricular dysfunction and to decrease the risk of sudden death. 5) Therefore, there is no uniform opinion as to whether or not valve surgery is necessary in patients with asymptomatic but severe AS. [5] [6] [7] In considering the pathophysiology of heart failure in AS, since the LV is exposed to the pressure overload for a long time, LV diastolic dysfunction may progress before systolic function deteriorates. Therefore, we believe that heart failure in AS must be evaluated according to the types of LV dysfunction, that is, systolic or diastolic dysfunction. Dineen, et al showed that 60% of the patients who exhibited heart failure in AS had normal LV ejection fraction, ie, developed diastolic heart failure, which resulted from the deterioration of LV compliance and relaxation.
3) Between these 2 types of heart failure, impaired systolic function has been considered to be the poorer prognostic index. However, there have been no conclusive investigations to determine whether the development of diastolic heart failure adversely affects the outcome of AS patients, especially in the postoperative course. The present study found that heart failure related to diastolic dysfunction in patients with AS did not affect the postoperative outcome. It is likely that as LV pressure overload is alleviated immediately after aortic valve surgery, LV diastolic properties may be quickly improved and PWP declines compared with patients with depressed LV systolic function. However, there are no conclusive data as to whether diastolic heart failure in AS precedes the development of LV systolic dysfunction or whether there are 2 etiological pathways for AS in the development of heart failure.
Recently, Rosenhek, et al reported that significant aortic valve calcification, coronary artery disease, and rapid progression of aortic jet velocity are indicators of poor outcome in patients with mild to moderate AS.
8) The presence of coronary artery diseases furthermore modifies the pathophysiology of AS and results in deteriorating LV systolic and diastolic function. 9, 10) However, the present investigation did not find that the presence of coronary artery disease is indicative of a poor outcome in AS, because only a few patients with preserved systolic function had significant coronary artery disease.
Doppler parameters of transmitral flow are useful to estimate LV diastolic function and left atrial pressure in patients with LV systolic dysfunction. However, in the hypertrophied heart it has been shown that the velocity ratio of early to atrial filling waves and the deceleration time of early filling do not correlate with the LV filling pressure. 11, 12) Currently, tissue Doppler echocardiography is considered suitable to noninvasively detect the progression of diastolic dysfunction or diastolic failure in patients with preserved LV systolic function. 13) It has been reported that B-type natriuretic peptide is a more sensitive marker of LV dysfunction than clinical status. Recently, Lim, et al revealed that the serum level of B-type natriuretic peptide is useful to differentiate symptomatic from asymptomatic patients with severe AS with preserved LV function, and that > 66 pg/mL is an accurate cut-off point to discriminate between these groups. [14] [15] [16] However, in determining the management for patients with severe AS, we generally believe that PWP and LVEF are important and convenient parameters. Study limitations: Recently, many reports have elucidated that B-type natriuretic peptide (BNP) is useful in assessing clinical status not only in patients with systolic heart failure, but also in those with diastolic heart failure. Since the present study was initiated in 1993 we did not measure BNP levels in all patients. In future, BNP may be useful for detecting AS with diastolic failure.
In this study, we examined only patients with severe AS who underwent cardiac catheterization. However, among these patients, only 10 exhibited asymptomatic AS. Therefore, if more patients with asymptomatic AS were included, it may be possible to further clarify diastolic dysfunction in AS. Conclusions: In patients with AS, diastolic heart failure developed in addition to systolic heart failure. The development of systolic heart failure in AS was regarded as poor during the postoperative course, but diastolic heart failure did not affect the outcome. Even when diastolic failure occurs in AS, the prognosis may still be good and AVR should be considered.
